AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IMATINIB
25 registrations across 7 African markets— 11 active
Markets with IMATINIB
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| IMATIS 100 MG TABLET; ORAL | 🇿🇼Zimbabwe | KEY ONCOLOGICS (PYT) LTD | active | Dec 2027 |
| IMATINIB DENK 400MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2026 |
| VATIVIO 100 | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | suspended | Aug 2024 |
| GLIVEC 400MG COMPRIME BOITE DE 30 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jun 2022 |
| GLIVEC 100MG COMPRIME PELLICULE BOITE DE 60 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Jun 2022 |
| IMATINIB DENK 100MG COMPRIME PELLICULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | DENK PHARMA GMBH & CO. KG | expired | Jan 2021 |
| IMATINIB NEAPOLIS Comprimé pelliculé / 400 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2020 |
| IMATINIB NEAPOLIS Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2020 |
| IMATINIB NEAPOLIS Comprimé pelliculé / 100 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2020 |
| IMATINIB_100 100MG FILM COATED TABLET FILM COATED TABLET | 🇲🇼Malawi | — | expired | Jun 2020 |
| IMATINIB_400 400MG FILM COATED TABLET FILM COATED TABLET | 🇲🇼Malawi | — | expired | Jun 2020 |
| IMATINIB OPALIA Gélule / 400 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Jul 2016 |
| IMATINIB OPALIA Gélule / 100 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Jul 2016 |
| CEMIVIL Comprimé pelliculé sécable / 100 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2014 |
| CEMIVIL Comprimé pelliculé sécable / 400 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Jan 2014 |
| GINIB 100 MG Tablet, Film-coated | 🇹🇿Tanzania | Eurolab (Pty) Ltd | active | — |
| GLIVEC COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| GINIB 400 Film Coated Tablet | 🇹🇿Tanzania | Eurolab (Pty) Ltd | active | — |
| IMATINIB COOPER GELULE | 🇲🇦Morocco | — | active | — |
| IMATINIB COOPER GELULE | 🇲🇦Morocco | — | active | — |
| GLIVEC COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| IMATEC GELULE | 🇲🇦Morocco | — | active | — |
| GLIVEC 400MG COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
| GLIVEC GELULE | 🇲🇦Morocco | — | active | — |
| GLIVEC 400MG COMPRIME PELLICULE | 🇲🇦Morocco | — | active | — |
IMATINIB in Africa — Regulatory Overview
IMATINIB is registered across 7 African markets with 25 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Côte d'Ivoire, Malawi and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 25 registrations, 11 (44%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.